{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:32:35Z","timestamp":1783744355275,"version":"3.55.0"},"reference-count":28,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2022JJ70161"],"award-info":[{"award-number":["2022JJ70161"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,12,9]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Opioid-induced constipation (OIC) affects up to 90% of patients with cancer receiving long-term opioid-related analgesic therapy, resulting in various potential complications, compromised pain management and decreased quality of life. Laxatives stimulate or facilitate bowel evacuation. Traditional laxatives, such as polyethylene glycol and lactulose, are widely used because of their low cost, easy accessibility and tolerability. OIC prophylaxis with laxatives is recommended for patients receiving opioid therapy. However, systematic reviews that support this practice are lacking. They have primarily focused on patients with existing constipation and the effectiveness of other pharmacological therapies. Thus, we are conducting a systematic review to evaluate the efficacy and safety of traditional laxatives in preventing OIC in adult patients with cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>The Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols 2015 statement was used to guide the reporting of this protocol. Database searches will be performed in PubMed, Embase, Web of Science, Cochrane Library and EBSCO from inception to a date within 6\u2009months of the submission of the full systematic review (estimated 31 December 2024). Reference lists will also be accessed for additional studies, including Google Scholar, for the inclusion of grey literature. A combination of Medical Subject Headings\/Emtree and free-text terms will be used when searching the core concepts of \u2018OIC\u2019, \u2018laxative\u2019 and \u2018cancer.\u2019 The eligibility criteria will be defined by the type of population (patients with cancer receiving opioid therapy), type of intervention (traditional laxatives) and type of study (randomised controlled trials and quasi-experimental trials). Two reviewers will independently select eligible studies, extract data and assess the methodological risk of bias. A third reviewer will be invited to reach a consensus if necessary. Subgroup and sensitivity analyses will be conducted to explore sources of heterogeneity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Ethical approval is not required, as patients will not be included in systematic reviews and meta-analyses. We will publish this study in a peer-reviewed journal and communicate the results at open conferences.<\/jats:p><jats:p><jats:bold>PROSPERO registration number<\/jats:bold><\/jats:p><jats:p>CRD42024507127.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2024-086001","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T12:50:12Z","timestamp":1735217412000},"page":"e086001","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Traditional laxatives in preventing opioid-induced constipation in adult patients with cancer: a systematic review and meta-analysis protocol"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3100-792X","authenticated-orcid":false,"given":"Yanfang","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-1242","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9392-6096","authenticated-orcid":false,"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3469-3709","authenticated-orcid":false,"given":"Haiyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4964-445X","authenticated-orcid":false,"given":"Ying-lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"2024122604500604000_14.12.e086001.1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030591","article-title":"Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis","volume":"15","author":"Snijders","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2024122604500604000_14.12.e086001.2","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-013-0344-2","article-title":"Opioid-induced bowel dysfunction","volume":"15","author":"Ketwaroo","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"key":"2024122604500604000_14.12.e086001.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.05.006"},{"key":"2024122604500604000_14.12.e086001.4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid\u2010induced constipation: European expert consensus statement","volume":"7","author":"Farmer","year":"2019","journal-title":"UEG Journal"},{"key":"2024122604500604000_14.12.e086001.5","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-017-0554-0","article-title":"Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice","volume":"19","author":"Simren","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"2024122604500604000_14.12.e086001.6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5055\/jom.2009.0014","article-title":"Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: Findings from the National Health and Wellness Survey","volume":"5","author":"Bell, MHA","year":"2018","journal-title":"J of Opioid Management"},{"key":"2024122604500604000_14.12.e086001.7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)","volume":"10","author":"Bell","year":"2009","journal-title":"Pain Med"},{"key":"2024122604500604000_14.12.e086001.8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00520-018-4366-z","article-title":"Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy","volume":"27","author":"Fine","year":"2019","journal-title":"Support Care Cancer"},{"key":"2024122604500604000_14.12.e086001.9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"key":"2024122604500604000_14.12.e086001.10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00520-019-05016-4","article-title":"MASCC recommendations on the management of constipation in patients with advanced cancer","volume":"28","author":"Davies","year":"2020","journal-title":"Support Care Cancer"},{"key":"2024122604500604000_14.12.e086001.11","doi-asserted-by":"crossref","first-page":"iv111","DOI":"10.1093\/annonc\/mdy148","article-title":"Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Larkin","year":"2018","journal-title":"Ann Oncol"},{"key":"2024122604500604000_14.12.e086001.12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.227132"},{"key":"2024122604500604000_14.12.e086001.13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.gastro.2018.08.018","article-title":"American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation","volume":"156","author":"Hanson","year":"2019","journal-title":"Gastroenterology"},{"key":"2024122604500604000_14.12.e086001.14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1188\/20.ONF.671-691","article-title":"for Opioid-Induced and Non-Opioid-Related Cancer Constipation","volume":"47","author":"Rogers","year":"2020","journal-title":"Oncol Nurs Forum"},{"key":"2024122604500604000_14.12.e086001.15","article-title":"Laxatives for the management of constipation in people receiving palliative care","volume":"2015","author":"Candy","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024122604500604000_14.12.e086001.16","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jpainsymman.2023.12.010","article-title":"The Management of Opioid-Induced Constipation in Cancer and Advanced Illness: A Meta-Analysis","volume":"67","author":"Jesuyajolu","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"2024122604500604000_14.12.e086001.17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamainternmed.2020.3285","article-title":"Preventing Opioid-Induced Constipation: A Teachable Moment","volume":"180","author":"Saha","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2024122604500604000_14.12.e086001.18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2468-1253(18)30008-6","article-title":"Pathophysiology, diagnosis, and management of opioid-induced constipation","volume":"3","author":"Farmer","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024122604500604000_14.12.e086001.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2011.01286.x"},{"key":"2024122604500604000_14.12.e086001.20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpainsymman.2012.02.008","article-title":"Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients","volume":"45","author":"Tarumi","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"2024122604500604000_14.12.e086001.21","doi-asserted-by":"crossref","unstructured":"Ozaki A , Kessoku T , Tanaka K , et al . n.d. Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial. Cancers (Basel) 14:2112. doi:10.3390\/cancers14092112","DOI":"10.3390\/cancers14092112"},{"key":"2024122604500604000_14.12.e086001.22","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.31557\/APJCP.2022.23.10.3473","article-title":"Constipation Severity and Quality of Life among Patients with Cancer Who Received Prophylactic Laxatives: Quasi-Experimental Study","volume":"23","author":"Ahmad","year":"2022","journal-title":"Asian Pac J Cancer Prev"},{"key":"2024122604500604000_14.12.e086001.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12904-023-01143-2","article-title":"Magnesium hydroxide versus macrogol\/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study)","volume":"22","author":"Kistemaker","year":"2023","journal-title":"BMC Palliat Care"},{"key":"2024122604500604000_14.12.e086001.24","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"2024122604500604000_14.12.e086001.25","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0000451683.66447.89"},{"key":"2024122604500604000_14.12.e086001.26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jrsm.1349","article-title":"Dealing with missing outcome data in meta-analysis","volume":"11","author":"Mavridis","year":"2020","journal-title":"Res Synth Methods"},{"key":"2024122604500604000_14.12.e086001.27","unstructured":"Higgins JPT , Thomas J , Chandler J , eds. Cochrane Handbook for Systematic Reviews of Interventions Version 2 6.5 (Updated August 2024).2024. Available: www.training.cochrane.org\/handbook"},{"key":"2024122604500604000_14.12.e086001.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.06.004"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-086001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T12:50:20Z","timestamp":1735217420000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-086001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,26]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/bmjopen-2024-086001"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-086001","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}